Publications
Specialty
Search
Vascular Disease Management, CardioVascular
04/05/2024
Join us for a Comprehensive Review of Cardiovascular Medicine to 20+ CMEs
NEW ORLEANS –Bringing physicians from around the world together for a comprehensive review of cardiovascular medicine, the 25th annual New Cardiovascular Horizons (NCVH) accredited conference will take place May 28-31 at The Roosevelt Hotel at 130 Roosevelt Way in New Orleans. New this year is a special 25th silver anniversary celebration for all on the Wednesday evening at the Orpheum Theater!
Vascular Disease Management, CardioVascular
Clarius and ThinkSono Introduce a New AI-Guided Ultrasound System Enabling Rapid Assessments of DVTs
04/05/2024
Having achieved CE Mark for sales in Europe and the UK, ThinkSono is now collaborating with Clarius on clinical studies in the United States to prepare for FDA submission
Journal of Clinical Pathways
04/05/2024
Ted Okon, MBA, discusses some of the latest pressing issues in Washington that are impacting oncology stakeholders, particularly in the community oncology setting.
ePlasty
04/04/2024
The efficacy and safety of a laser-assisted lipolysis device emitting 1444 nm was evaluated for the treatment of pseudogynecomastia.
Journal of Invasive Cardiology, CardioVascular
04/04/2024
Dr. Deepak L. Bhatt catches up with Dr. Emmanouil S. Brilakis about his Editor’s 2023 Top 10 article, “Equipment Utilization in Chronic Total Occlusion Percutaneous Coronary Interventions: Update From the PROGRESS-CTO Registry.”
Pharmacy Learning Network
04/04/2024
On April 3, 2024, Sanofi agreed to settle its 4,000 lawsuits prompted by the discontinued Zantac due to its link to cancer, according to a recent Reuters article. The plaintiffs in the case claim Zantac causes cancer due to the active ingredient ranitidine and its potential to evolve into NDMA, a known carcinogen when exposed to heat over time.
ePlasty, Surgery
04/04/2024
This study evaluated real-world effectiveness of PCMP versus CCSA in a large DFU patient population.
Cath Lab Digest, Journal of Invasive Cardiology, CardioVascular
04/04/2024
For nearly two decades, CRF® has led the way in pioneering transcatheter therapies for structural heart disease at TVT®. New York Valves marks the next iteration of this legacy, featuring three days of transformative research and techniques that will redefine the landscape of structural heart interventions.
Cath Lab Digest, Journal of Invasive Cardiology, Vascular Disease Management
04/04/2024
The research team analyzed deaths after PCI occurring at 39 Michigan hospitals participating in BMC2 between 2012 and 2014. These hospitals use procedural and outcome data to inform quality projects to improve care and patient outcomes.
APP Institute Oncology
04/04/2024
This quiz series explores common targets and therapies for patients with intrahepatic cholangiocarcinoma.
Pharmacy Learning Network
04/04/2024
The former owner and operator of a pharmacy in Grosse Pointe Park, Michigan, was convicted by a federal jury on 26 charges related to the unlawful distribution of controlled substances.
Oncology
04/04/2024
According to results from the phase 2 PACE study, the addition of palbociclib to fulvestrant did not improve PFS among patients with HR-positive, HER2-negative metastatic breast cancer who experienced disease progression after treatment with a CDK4/6 inhibitor plus an aromatase inhibitor.
Oncology
04/04/2024
According to interim results from an international phase 3 trial, ribociclib plus either letrozole or anastrozole significantly improved disease-free survival among patients with HR-positive, HER2-negative early breast cancer.
Oncology
04/04/2024
According to results from the phase 3 PAPILLON trial, what percentage of patients remained on amivantamab plus chemotherapy at a follow-up of 18-months?
Oncology
04/04/2024
True or False: Results from the innovaTV 301/ENGOT-cx12/GOG-3057 trial demonstrated that tisotumab vedotin in the second-/third-line setting significantly improved survival and response outcomes compared to chemotherapy for patients with recurrent or metastatic cervical cancer, regardless of tissue factor expression.
Journal of Invasive Cardiology, CardioVascular
04/04/2024
Dr Deepak L. Bhatt catches up with Dr J. Ribamar Costa about his Editor’s 2023 Top 10 article, “Serial Assessment of Coronary Artery Healing of a Biodegradable Polymer Drug-Eluting Stent at 1, 2, and 3 Months by Optical Coherence Tomography (OCT)—The REPAIR Trial.”
Psych Congress Network
04/04/2024
Unlock the intricacies of bipolar disorder diagnosis and what the DSM-5 says with experts Julie Carbray, PhD, and Jim Phelps, MD, in this insightful discussion.
First Report Managed Care
04/04/2024
The development of inhibitors in patients with hemophilia poses challenges for achieving perioperative hemostasis and may result in complications and deviations from the surgical plan, highlighting the need for strategies to address inhibitor development.
Journal of Invasive Cardiology, CardioVascular
04/04/2024
Dr Mohammad Reza Movahed shares background and insights on his paper, “Various Techniques for Transcatheter Retrieval of Atrial Septal Defect or Patent Foramen Ovale Closure Devices: A Systematic Review.”
Integrated Healthcare Executive
04/04/2024
US health clinics continue to struggle as the aftermath of a major cyberattack on Change Healthcare unfolds, prompting senior Biden Administration officials to warn of potential issues with access to care and the need for financial assistance for smaller providers.
Current Issue
September 2024
Volume
Issue
Enter Your E-mail
EMSWorld Newsletter
